What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
about
Citalopram versus other anti-depressive agents for depressionReview of Cohort Studies for Mood DisordersUpdate on Neuromodulation for Treatment-Resistant DepressionOptimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeIdentification and treatment of depression in minority populations.Addressing Missing Data Mechanism Uncertainty using Multiple-Model Multiple Imputation: Application to a Longitudinal Clinical Trial.Identifying risk for attrition during treatment for depression.Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity.The impact of disability on depression among individuals with COPD.Predictors of attrition during one year of depression treatment: a roadmap to personalized interventionEnduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant responsePatient-reported outcomes before and after treatment of major depressive disorder.Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.The development of the DSM-5 Cultural Formulation Interview-Fidelity Instrument (CFI-FI): a pilot study.Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.Impact of motivational pharmacotherapy on treatment retention among depressed LatinosDesign and inference for the intent-to-treat principle using adaptive treatment.The long-term trajectory of depression among Latinos in primary care and its relationship to depression care disparities.Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatientsMeasuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart reviewDepression, Help-Seeking and Self-Recognition of Depression among Dominican, Ecuadorian and Colombian Immigrant Primary Care Patients in the Northeastern United StatesUndiagnosed Drug Misuse among Admissions to Psychiatric Day Treatment and Prediction of Early Exit.Clinician descriptions of communication strategies to improve treatment engagement by racial/ethnic minorities in mental health services: A systematic review.Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People's Republic of China.Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray?Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerabilitySTAR*D: has it taught us anything about the management of depression?Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?Clinical issues in use of atypical antipsychotics for depressed patients.Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.Transcranial magnetic stimulation for treatment of major depression during pregnancy: a review.Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects.Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.Racial and Ethnic Disparity in Major Depressive Disorder.A randomized-controlled trial of an intervention to improve antidepressant adherence among Latinos with depression.Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.Vagus Nerve Stimulation (VNS) and Other Augmentation Strategies for Therapy-Resistant Depression (TRD): Review of the Evidence and Clinical Advice for Use.
P2860
Q24202141-4820CDD9-AE3F-4FDD-BD65-5492026BF9CAQ26744364-0AB32D8B-4751-416D-B6D0-D2890D32A2B6Q26766211-B6AF583E-8392-4CC5-A993-2FE000F48E5BQ26797416-616B90E3-CECC-4E27-B445-19428DA2D75AQ30413593-A34BBB33-883F-4F4B-889C-98A1038168DFQ30600783-EC786BD5-1BF7-4753-A3D1-59C3F60BC2E5Q33646530-7A05293E-0031-4943-83CD-7E841F0E3278Q33765242-E689BC5E-4E82-445A-A91C-66578874AC83Q33776860-BAE53340-5E38-4A68-B8EB-9C28D1C941D7Q33836094-23E2538E-DC5A-4B0C-863D-7056643445DEQ33983943-F576ABD4-CA0A-4B19-8589-828B24F54E9DQ34074658-0C2A07D8-7CFF-4926-A9BD-B867B8D337A8Q34713784-EE16697A-4DE9-446A-B840-88397C414587Q35012786-9808EF0D-42BD-4D2B-8F5E-E2C5473D0C77Q35054544-B4E6E95E-E8FD-41A1-B985-C4985FEC3AEAQ35058467-04CF8AB9-5558-43A4-882D-9925E9347449Q35090784-5A43170E-8F6E-4CBC-A2F0-D476AAF7D0B4Q35328058-8939D91A-0CC9-4806-821B-1B4649E8F87FQ35393686-3475BDE3-4B0E-4A23-818D-8E7F108E2634Q36024493-9C3E700B-44DC-4424-897F-CCD6578E7B1EQ36091252-23DEC158-F516-44D2-9A10-9519BADDC0F9Q36102316-E4A09092-BBBD-4A04-BD90-60A3C4574CC9Q36481500-FF3CC061-A2F6-4018-A4BE-4C7BD29236E4Q36522062-284CE1A8-9458-443F-B188-2258B9A2C01DQ36833956-9BC23C33-C28C-40CE-90ED-6B47AC57493AQ37282117-9BBD3EDF-C98F-4683-AFEF-83DB63A9A20FQ37429825-2025CDE2-B89B-4D91-98D4-D80DA7FFA0AEQ37747496-9DA6D1A0-6F49-4E39-8534-F411EF54266AQ37958033-A967AAD7-D939-4FE2-9027-B9989B22EAE6Q38109591-48188623-C844-4D26-86B2-A6FE16DF733BQ38125219-65AFFF8A-3797-4624-9D06-ACEBEB567465Q39026884-48303E96-E4D7-483A-A4FD-525CE5E933E7Q42694571-3C966B48-2D5A-4A19-8A0D-B3AB372299DCQ47556460-CC0852BB-4B70-48E6-BDC0-BC535EECFE6BQ48002729-E194AF72-EF68-4592-84C1-3281CD37CEFEQ48544253-9A1481CA-1A3C-4E2F-8D93-72E1782858B7Q48773640-8F364DE7-4BD3-40E9-A948-EAC06FB8A537Q53691732-7BBBC205-BD0E-4A7A-B0F4-87B2C25C89D1
P2860
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
What predicts attrition in sec ...... depression?: a STAR*D Report.
@en
type
label
What predicts attrition in sec ...... depression?: a STAR*D Report.
@en
prefLabel
What predicts attrition in sec ...... depression?: a STAR*D Report.
@en
P2093
P2860
P1476
What predicts attrition in sec ...... r depression?: a STAR*D Report
@en
P2093
Andrew A Nierenberg
Diane Warden
Elizabeth A Young
G K Balasubramani
Ira M Lesser
Kathy Shores-Wilson
Madhukar H Trivedi
Michael E Thase
Sheldon H Preskorn
Susan G Kornstein
P2860
P304
P356
10.1017/S1461145708009073
P577
2008-07-09T00:00:00Z